{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:41:39Z","timestamp":1785796899792,"version":"3.56.0"},"reference-count":66,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T00:00:00Z","timestamp":1514332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Red blood cells and platelets are anucleate blood components indispensable for oxygen delivery and hemostasis, respectively. Derivation of these blood elements from induced pluripotent stem (iPS) cells has the potential to develop blood donor-independent and genetic manipulation-prone products to complement or replace current transfusion banking, also minimizing the risk of alloimmunization. While the production of erythrocytes from iPS cells has challenges to overcome, such as differentiation into adult-type phenotype that functions properly after transfusion, platelet products are qualitatively and quantitatively approaching a clinically-applicable level owing to advances in expandable megakaryocyte (MK) lines, platelet-producing bioreactors, and novel reagents. Guidelines that assure the quality of iPS cells-derived blood products for clinical application represent a novel challenge for regulatory agencies. Considering the minimal risk of tumorigenicity and the expected significant demand of such products, ex vivo production of iPS-derived blood components can pave the way for iPS translation into the clinic.<\/jats:p>","DOI":"10.3390\/cells7010002","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T11:16:00Z","timestamp":1514373360000},"page":"2","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Induced Pluripotent Stem Cell-Derived Red Blood Cells and Platelet Concentrates: From Bench to Bedside"],"prefix":"10.3390","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8811-195X","authenticated-orcid":false,"given":"Daniele","family":"Focosi","sequence":"first","affiliation":[{"name":"North-Western Tuscany Blood Bank, Pisa University Hospital, via Paradisa 2, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Amabile","sequence":"additional","affiliation":[{"name":"ADIENNE, via Zurigo 46, 6900 Lugano, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,12,27]]},"reference":[{"key":"ref_1","unstructured":"(2017, December 24). WHO Model List of Essential Medicines for Adults, 19th List (April 2015) Rev.. Available online: http:\/\/www.who.int\/selection_medicines\/committees\/expert\/20\/EML_2015_FINAL_amended_AUG2015.pdf?ua=1."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1537-2995.2009.02490.x","article-title":"The aging population poses a global challenge for blood services","volume":"50","author":"Ali","year":"2010","journal-title":"Transfusion"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/j.1537-2995.2008.01828.x","article-title":"In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells","volume":"48","author":"Baek","year":"2008","journal-title":"Transfusion"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood-2006-02-003327","article-title":"Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures","volume":"108","author":"Vodyanik","year":"2006","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1182\/blood-2008-09-178863","article-title":"A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis","volume":"114","author":"Klimchenko","year":"2009","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1182\/blood-2008-05-157198","article-title":"Biologic properties and enucleation of red blood cells from human embryonic stem cells","volume":"112","author":"Lu","year":"2008","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1038\/ncomms5372","article-title":"Direct induction of haematoendothelial programs in human pluripotent stem cells by transcriptional regulators","volume":"5","author":"Elcheva","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/1073110516667939","article-title":"The New Federalism: State Policies Regarding Embryonic Stem Cell Research","volume":"44","author":"Acosta","year":"2016","journal-title":"J. Law Med. Ethics"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"26384","DOI":"10.1074\/jbc.M110.115915","article-title":"Generation of genome integration-free induced pluripotent stem cells from fibroblasts of C57BL\/6 mice without c-Myc transduction","volume":"285","author":"Jincho","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1016\/j.biomaterials.2011.05.009","article-title":"Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells","volume":"32","author":"Li","year":"2011","journal-title":"Biomaterials"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1084\/jem.20121044","article-title":"Poly(ADP-ribose) polymerase 1 regulates nuclear reprogramming and promotes iPSC generation without c-Myc","volume":"210","author":"Chiou","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nature11333","article-title":"Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2","volume":"488","author":"Doege","year":"2012","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1101\/gr.106773.110","article-title":"Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome","volume":"20","author":"Choi","year":"2010","journal-title":"Genome Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1566523211313020002","article-title":"Technological overview of iPS induction from human adult somatic cells","volume":"13","author":"Bayart","year":"2013","journal-title":"Curr. Gene Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2012-06-434407","article-title":"In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells","volume":"121","author":"Amabile","year":"2013","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.molmed.2008.12.003","article-title":"Induced pluripotent stem cells: Current progress and potential for regenerative medicine","volume":"15","author":"Amabile","year":"2009","journal-title":"Trends Mol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1038\/bcj.2014.30","article-title":"Induced pluripotent stem cells in hematology: Current and future applications","volume":"4","author":"Focosi","year":"2014","journal-title":"Blood Cancer J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1038\/ncomms8091","article-title":"Dissecting the role of aberrant DNA methylation in human leukaemia","volume":"6","author":"Amabile","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Li, M., Cascino, P., Ummarino, S., and Di Ruscio, A. (2017). Application of Induced Pluripotent Stem Cell Technology to the Study of Hematological Diseases. Cells, 6.","DOI":"10.3390\/cells6010007"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/trf.12317","article-title":"Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody response","volume":"54","author":"Jackman","year":"2014","journal-title":"Transfusion"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1537-2995.2012.03715.x","article-title":"Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?","volume":"53","author":"Fast","year":"2013","journal-title":"Transfusion"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5966\/sctm.2015-0257","article-title":"Effect of Induced Pluripotent Stem Cell Technology in Blood Banking","volume":"5","author":"Focosi","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.exphem.2013.04.007","article-title":"Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes","volume":"41","author":"Nakagawa","year":"2013","journal-title":"Exp. Hematol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Chen, H.Y., Tan, H.K., and Loh, Y.H. (2016). Derivation of Transgene-Free Induced Pluripotent Stem Cells from a Single Drop of Blood. Curr. Protoc. Stem Cell Biol., 38.","DOI":"10.1002\/cpsc.12"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nmeth.1593","article-title":"Chemically defined conditions for human iPSC derivation and culture","volume":"8","author":"Chen","year":"2011","journal-title":"Nat. Methods"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.stemcr.2014.09.010","article-title":"Scalable Generation of Universal Platelets from Human Induced Pluripotent Stem Cells","volume":"3","author":"Feng","year":"2014","journal-title":"Stem Cell Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.5966\/sctm.2015-0371","article-title":"High-Efficiency Serum-Free Feeder-Free Erythroid Differentiation of Human Pluripotent Stem Cells Using Small Molecules","volume":"5","author":"Olivier","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Borst, S., Sim, X., Poncz, M., French, D.L., and Gadue, P. (2017). Induced Pluripotent Stem Cell-Derived Megakaryocytes and Platelets for Disease Modeling and Clinical Use. Arterioscler. Thromb. Vasc. Biol.","DOI":"10.1161\/ATVBAHA.117.309197"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1097\/01.tp.0000287318.94088.d7","article-title":"Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants","volume":"84","author":"Asano","year":"2007","journal-title":"Transplantation"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Chang, C.J., Mitra, K., Koya, M., Velho, M., Desprat, R., Lenz, J., and Bouhassira, E.E. (2011). Production of embryonic and fetal-like red blood cells from human induced pluripotent stem cells. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025761"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1089\/scd.2011.0078","article-title":"Generation of red blood cells from human induced pluripotent stem cells","volume":"20","author":"Dias","year":"2011","journal-title":"Stem Cells Dev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3324\/haematol.2010.023556","article-title":"Red blood cell generation from human induced pluripotent stem cells: Perspectives for transfusion medicine","volume":"95","author":"Lapillonne","year":"2010","journal-title":"Haematologica"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3324\/haematol.2011.055566","article-title":"Human induced pluripotent stem cells can reach complete terminal maturation: In vivo and in vitro evidence in the erythropoietic differentiation model","volume":"97","author":"Kobari","year":"2012","journal-title":"Haematologica"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000477357","article-title":"Emergence of CD43-Expressing Hematopoietic Progenitors from Human Induced Pluripotent Stem Cells","volume":"44","author":"Kessel","year":"2017","journal-title":"Transfus. Med. Hemother."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Merryweather-Clarke, A.T., Tipping, A.J., Lamikanra, A.A., Fa, R., Abu-Jamous, B., Tsang, H.P., Carpenter, L., Robson, K.J., Nandi, A.K., and Roberts, D.J. (2016). Distinct gene expression program dynamics during erythropoiesis from human induced pluripotent stem cells compared with adult and cord blood progenitors. BMC Genom., 17.","DOI":"10.1186\/s12864-016-3134-z"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Trakarnsanga, K., Wilson, M.C., Griffiths, R.E., Toye, A.M., Carpenter, L., Heesom, K.J., Parsons, S.F., Anstee, D.J., and Frayne, J. (2014). Qualitative and quantitative comparison of the proteome of erythroid cells differentiated from human iPSCs and adult erythroid cells by multiplex TMT labelling and nanoLC-MS\/MS. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100874"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/bjh.14491","article-title":"A molecular roadmap of definitive erythropoiesis from human induced pluripotent stem cells","volume":"176","author":"Razaq","year":"2017","journal-title":"Br. J. Haematol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1101\/gad.1897310","article-title":"Transcriptional silencing of \u03b3-globin by BCL11A involves long-range interactions and cooperation with SOX6","volume":"24","author":"Xu","year":"2010","journal-title":"Genes Dev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1182\/blood-2011-03-331371","article-title":"The multifunctional role of EKLF\/KLF1 during erythropoiesis","volume":"118","author":"Siatecka","year":"2011","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/stem.2517","article-title":"Efficient Generation of beta-Globin-Expressing Erythroid Cells Using Stromal Cell-Derived Induced Pluripotent Stem Cells from Patients with Sickle Cell Disease","volume":"35","author":"Uchida","year":"2017","journal-title":"Stem Cells"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/stem.2562","article-title":"Activation of KLF1 Enhances the Differentiation and Maturation of Red Blood Cells from Human Pluripotent Stem Cells","volume":"35","author":"Yang","year":"2017","journal-title":"Stem Cells"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1089\/ten.tec.2015.0579","article-title":"Superior Red Blood Cell Generation from Human Pluripotent Stem Cells Through a Novel Microcarrier-Based Embryoid Body Platform","volume":"22","author":"Sivalingam","year":"2016","journal-title":"Tissue Eng. Part C Methods"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.stem.2016.06.019","article-title":"Epigenetic Variation between Human Induced Pluripotent Stem Cell Lines Is an Indicator of Differentiation Capacity","volume":"19","author":"Nishizawa","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13578-016-0111-9","article-title":"Improved hematopoietic differentiation of human pluripotent stem cells via estrogen receptor signaling pathway","volume":"6","author":"Kim","year":"2016","journal-title":"Cell Biosci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.stem.2015.09.015","article-title":"Targeted Application of Human Genetic Variation Can Improve Red Blood Cell Production from Stem Cells","volume":"18","author":"Giani","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Doulatov, S., Vo, L.T., Macari, E.R., Wahlster, L., Kinney, M.A., Taylor, A.M., Barragan, J., Gupta, M., McGrath, K., and Lee, H.Y. (2017). Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors. Sci. Transl. Med., 9.","DOI":"10.1126\/scitranslmed.aah5645"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/sctm.16-0121","article-title":"Enhancement of beta-Globin Gene Expression in Thalassemic IVS2-654 Induced Pluripotent Stem Cell-Derived Erythroid Cells by Modified U7 snRNA","volume":"6","author":"Phanthong","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.stemcr.2016.12.017","article-title":"A Comprehensive, Ethnically Diverse Library of Sickle Cell Disease-Specific Induced Pluripotent Stem Cells","volume":"8","author":"Park","year":"2017","journal-title":"Stem Cell Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2012-02-413617","article-title":"Induction of functional platelets from mouse and human fibroblasts by p45NF-E2\/Maf","volume":"120","author":"Ono","year":"2012","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.celrep.2016.09.036","article-title":"Direct Conversion of Fibroblasts to Megakaryocyte Progenitors","volume":"17","author":"Pulecio","year":"2016","journal-title":"Cell Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/VHRM.S44469","article-title":"Platelet function tests: A comparative review","volume":"11","author":"Paniccia","year":"2015","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1084\/jem.20100844","article-title":"Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells","volume":"207","author":"Takayama","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1084\/jem.20102428","article-title":"Induced pluripotent stem cell-derived human platelets: One step closer to the clinic","volume":"207","author":"Gekas","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1089\/scd.2012.0701","article-title":"Generation of functional platelets from canine induced pluripotent stem cells","volume":"22","author":"Nishimura","year":"2013","journal-title":"Stem Cells Dev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2014-05-574913","article-title":"Platelet bioreactor-on-a-chip","volume":"124","author":"Thon","year":"2014","journal-title":"Blood"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.stem.2014.01.011","article-title":"Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells","volume":"14","author":"Nakamura","year":"2014","journal-title":"Cell Stem Cell"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1111\/jth.13736","article-title":"Platelet production from induced pluripotent stem cells","volume":"15","author":"Sugimoto","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"720","DOI":"10.5966\/sctm.2016-0104","article-title":"Selective Inhibition of ADAM17 Efficiently Mediates Glycoprotein Ibalpha Retention During Ex Vivo Generation of Human Induced Pluripotent Stem Cell-Derived Platelets","volume":"6","author":"Hirata","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Borger, A.K., Eicke, D., Wolf, C., Gras, C., Aufderbeck, S., Schulze, K., Engels, L., Eiz-Vesper, B., Schambach, A., and Guzman, C.A. (2016). Generation of HLA-universal iPSCs-derived megakaryocytes and platelets for survival under refractoriness conditions. Mol. Med., 22.","DOI":"10.2119\/molmed.2015.00235"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1089\/hum.2013.074","article-title":"HLA-universal platelet transfusions prevent platelet refractoriness in a mouse model","volume":"24","author":"Gras","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Kammers, K., Taub, M.A., Ruczinski, I., Martin, J., Yanek, L.R., Frazee, A., Gao, Y., Hoyle, D., Faraday, N., and Becker, D.M. (2017). Integrity of Induced Pluripotent Stem Cell (iPSC) Derived Megakaryocytes as Assessed by Genetic and Transcriptomic Analysis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0167794"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"11208","DOI":"10.1038\/ncomms11208","article-title":"Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming","volume":"7","author":"Moreau","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1537-2995.2010.02984.x","article-title":"Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation","volume":"51","author":"Fast","year":"2011","journal-title":"Transfusion"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/7\/1\/2\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:55:46Z","timestamp":1760208946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/7\/1\/2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,27]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1]]}},"alternative-id":["cells7010002"],"URL":"https:\/\/doi.org\/10.3390\/cells7010002","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,27]]}}}